Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8630386 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)
Condition: Asthma
Interventions: Drug: Imatinib mesylate;   Drug: Placebo

Indicates status has not been verified in more than two years